Provided by Tiger Trade Technology Pte. Ltd.

ASTRAZENECA PLC ADRhedged

53.28
0.0000
Volume:- -
Turnover:- -
Market Cap:1.60M
PE:- -
High:53.28
Open:53.28
Low:53.28
Close:53.28
52wk High:56.90
52wk Low:44.36
Shares:30.00K
Float Shares:10.00K
Volume Ratio:- -
T/O Rate:- -
Dividend:0.58
Dividend Rate:1.08%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

AstraZeneca PLC Stock Falls Wednesday, Underperforms Market

Dow Jones
·
1 hour ago

The 'CIA' Strategy Beating the Market: How One Top-Performing Money Manager Spots Mispriced Stocks.

Dow Jones
·
Yesterday

AstraZeneca's Long-Term Outlook Could Look Safer After Next Year

Dow Jones
·
Yesterday

AstraZeneca Can Meet 2030 Target Even if Lung-Cancer Trial Fails

Dow Jones
·
Yesterday

Guardant Health Could Benefit From AstraZeneca Trial Failure, UBS Says

MT Newswires Live
·
Yesterday

AstraZeneca price target lowered to 150 GBp from 160 GBp at Berenberg

TIPRANKS
·
Yesterday

Berenberg Trims Price Target on AstraZeneca to $203 From $214, Keeps Buy Rating

MT Newswires Live
·
Sep 15

AstraZeneca's Portfolio Diversity Bodes Well

Dow Jones
·
Sep 15

Berenberg Bank Remains a Buy on AstraZeneca (AZN)

TIPRANKS
·
Sep 15

Top Midday Decliners

MT Newswires Live
·
Sep 15

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
Sep 15

AstraZeneca Can Overcome Recent Trial Setbacks

Dow Jones
·
Sep 14

Dow Jones Top Company Headlines at 11 am ET: Microsoft Sets Limits for AI Models as Altman Details Control Risks | Dell's ...

Dow Jones
·
Sep 14

AstraZeneca, Daiichi Drug Has Good Lung-Cancer Data, but Competition Awaits

Dow Jones
·
Sep 14

Sector Update: Healthcare Stocks Rise Premarket Monday

MT Newswires Live
·
Sep 14

AstraZeneca reports results from DESTINY-Lung04 trial

TIPRANKS
·
Sep 14

AstraZeneca reports updated exploratory results from ADAURA trial

TIPRANKS
·
Sep 14

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Sep 14

Astrazeneca Says Cancer Drugs Enhertu, Tagrisso Show Survival Benefits in Late-Stage Trials

MT Newswires Live
·
Sep 14

AstraZeneca Breast-Cancer Drug Misses Goal in Late-Stage Trial

Dow Jones
·
Sep 14